Ondansetron Kalceks

Ondansetron, the active ingredient in Ondansetron Kalceks, is a 5-HT3 receptor antagonist presented as an injectable solution for intramuscular and intravenous use. It prevents nausea and vomiting associated with chemotherapy, surgery, and radiation therapy in patients undergoing these treatments.

GNH USA supplies Ondansetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide. The company ensures quality compliance with EU standards and provides reliable logistics for global distribution.

Ondansetron acts on the serotonin-mediated pathway that triggers nausea and vomiting, making it useful in several clinical settings.

- Chemotherapy-induced nausea and vomiting: reduces frequency and severity of acute and delayed episodes. - Postoperative nausea and vomiting: prevents onset of nausea and vomiting after surgical procedures. - Radiation-induced nausea and vomiting: mitigates nausea associated with radiotherapy sessions.

Ondansetron may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Constipation: reduced bowel movements. - Diarrhoea: loose stools. - Fatigue: feeling of tiredness.

Serious or Rare Side Effects: - QT interval prolongation: potential cardiac arrhythmia. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Serotonin syndrome: agitation, hyperreflexia, or hyperthermia when combined with serotonergic agents.

When using Ondansetron, several precautions should be observed to ensure safe administration.

- Cardiac monitoring: assess baseline ECG in patients with known heart disease. - Electrolyte balance: correct hypokalaemia or hypomagnesaemia before use. - Drug interactions: review concomitant medications that may affect QT interval. - Pregnancy: avoid unless benefit outweighs risk, as safety data are limited. - Lactation: consider potential excretion in breast milk and monitor infant. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ondansetron can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Apomorphine: may cause severe hypotension and loss of consciousness. - Certain antiarrhythmics (e.g., amiodarone, sotalol): increase risk of QT prolongation.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs, MAO inhibitors): potential for serotonin syndrome. - Antifungal agents (ketoconazole, fluconazole): may raise ondansetron plasma levels. - Chemotherapy agents (cisplatin, cyclophosphamide): may enhance emetogenic risk if ondansetron dose is inadequate.